162 related articles for article (PubMed ID: 2381868)
21. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
Paradowski A; Dynowski Z; Kubik A; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
[TBL] [Abstract][Full Text] [Related]
23. Further investigations on the antinociceptive activity of tuftsin analogs.
Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
[TBL] [Abstract][Full Text] [Related]
24. Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.
Surkis R; Rubinraut S; Dagan S; Tzehoval E; Fridkin M; Ben Yoseph R; Catane R
Int J Biochem; 1990; 22(2):193-5. PubMed ID: 2332102
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological activity of tuftsin, its analogue and conjugates containing muramyl dipeptides or nor-muramyl dipeptides.
Dzierzbicka K; Trzonkowski P; Sewerynek P; Kolodziejczyk AM; Myśliwski A
J Pept Sci; 2005 Mar; 11(3):123-35. PubMed ID: 15635647
[TBL] [Abstract][Full Text] [Related]
26. The evidence on the possible interleukin-1 alpha tuftsin competition.
Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of modified tuftsins containing monosaccharides or monosaccharide derivatives.
Rocchi R; Biondi L; Filira F; Gobbo M; Dagan S; Fridkin M
Int J Pept Protein Res; 1987 Feb; 29(2):250-61. PubMed ID: 3570665
[TBL] [Abstract][Full Text] [Related]
28. Quenched molecular dynamics simulations of tuftsin and proposed cyclic analogues.
O'Connor SD; Smith PE; al-Obeidi F; Pettitt BM
J Med Chem; 1992 Jul; 35(15):2870-81. PubMed ID: 1495018
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometric identification of the trypsin cleavage pathway in lysyl-proline containing oligotuftsin peptides.
Manea M; Mezo G; Hudecz F; Przybylski M
J Pept Sci; 2007 Apr; 13(4):227-36. PubMed ID: 17394121
[TBL] [Abstract][Full Text] [Related]
30. [Stimulation of oxygen metabolism in human blood phagocytes as affected by tuftsin-like peptides derived from the C-reactive protein molecule].
Polevshchikov AV; Nazarov PG
Biull Eksp Biol Med; 1993 Jan; 115(1):55-6. PubMed ID: 8054580
[TBL] [Abstract][Full Text] [Related]
31. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
32. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
Buchta R; Fridkin M; Pontet M; Romeo D
Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
[TBL] [Abstract][Full Text] [Related]
33. Enhanced cleavage of diaminopimelate-containing isopeptides by leucine aminopeptidase and matrix metalloproteinases in tumors: application to bioadhesive peptides.
Yamazaki Y; Savva M; Kleinman HK; Oka S; Mokotoff M
J Pept Res; 1999 Feb; 53(2):177-87. PubMed ID: 10195455
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activity of [L-3,4-dehydroproline3]-tuftsin.
Amoscato AA; Babcock GF; Nishioka K
Peptides; 1984; 5(3):489-94. PubMed ID: 6548023
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of an IgG fragment decapeptide exhibiting phagocytosis stimulating activity of polymorphonuclear leucocytes.
Martinez J; Laur J; Winternitz F
Int J Pept Protein Res; 1983 Jul; 22(1):119-24. PubMed ID: 6885245
[TBL] [Abstract][Full Text] [Related]
36. Solid-phase tuftsin (Thr-Lys-Pro-Arg) synthesis: deprotection and resin cleavage with trifluoromethane sulfonic acid.
Chaudhuri MK; Najjar VA
Anal Biochem; 1979 May; 95(1):305-10. PubMed ID: 227288
[No Abstract] [Full Text] [Related]
37. Synthesis and immunological evaluation of the conjugates composed from a muramyl peptide GMDP and tuftsin.
Titov VM; Meshcheryakova EA; Balashova TA; Andronova TM; Ivanov VT
Int J Pept Protein Res; 1995 Apr; 45(4):348-55. PubMed ID: 7601608
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of tritiated tuftsin and macrophage inhibitory tripeptide via acetylenic intermediates.
Auger G; Blanot D
Int J Pept Protein Res; 1984 Jul; 24(1):60-5. PubMed ID: 6548204
[TBL] [Abstract][Full Text] [Related]
39. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
Fridkin M; Tsubery H; Tzehoval E; Vonsover A; Biondi L; Filira F; Rocchi R
J Pept Sci; 2005 Jan; 11(1):37-44. PubMed ID: 15635725
[TBL] [Abstract][Full Text] [Related]
40. New conjugates of muramyl dipeptide and nor-muramyl dipeptide linked to tuftsin and retro-tuftsin derivatives significantly influence their biological activity.
Dzierzbicka K; Wardowska A; Rogalska M; Trzonkowski P
Pharmacol Rep; 2012; 64(1):217-23. PubMed ID: 22580539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
